Luca Malorni
Prato, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
The secret life of a cell-cycle gatekeeper of breast cancer.
Journal: Nature
Published: September 07, 2026
The genomic landscape of HER2 negative metastatic breast cancer with loss of estrogen and progesterone receptors.
Journal: Breast (Edinburgh, Scotland)
Published: October 07, 2025
A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing.
Journal: Genome medicine
Published: August 01, 2025
ctDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 25, 2025
Efficacy and safety of systemic therapies following progression on CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: a systematic review and network meta-analysis.
Journal: EClinicalMedicine
Published: July 15, 2025
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 05, 2025
Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies.
Journal: Cancer treatment reviews
Published: April 24, 2025
Key decision factors in second-line therapy: Expert insights on HR+/HER2-metastatic breast cancer post-CDK4/6 inhibitor progression.
Journal: Cancer treatment reviews
Published: March 27, 2025
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 07, 2025
Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines.
Journal: NPJ breast cancer
Published: February 27, 2025
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report.
Journal: Critical reviews in oncology/hematology
Published: January 29, 2025
Last Updated: 09/26/2026